• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency.

作者信息

Gonzalez F J, Fernandez-Salguero P

机构信息

Laboratory of Molecular Carcinogenesis, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Trends Pharmacol Sci. 1995 Oct;16(10):325-7. doi: 10.1016/s0165-6147(00)89065-3.

DOI:10.1016/s0165-6147(00)89065-3
PMID:7491709
Abstract
摘要

相似文献

1
Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency.
Trends Pharmacol Sci. 1995 Oct;16(10):325-7. doi: 10.1016/s0165-6147(00)89065-3.
2
Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy.
Pharmacogenetics. 1994 Dec;4(6):301-6. doi: 10.1097/00008571-199412000-00002.
3
A new case of dihydropyrimidine dehydrogenase deficiency.
J Inherit Metab Dis. 1990;13(1):121-4. doi: 10.1007/BF01799339.
4
Dihydropyrimidine dehydrogenase deficiency in a Hutterite newborn.
Adv Exp Med Biol. 1991;309B:311-4. doi: 10.1007/978-1-4615-7703-4_69.
5
Dihydropyrimidine dehydrogenase deficiency. Identification of two novel mutations and expression of missense mutations in E. coli.二氢嘧啶脱氢酶缺乏症。两种新突变的鉴定及错义突变在大肠杆菌中的表达。
Adv Exp Med Biol. 1998;431:341-6.
6
Determination of dihydropyrimidine dehydrogenase (DPD) in fibroblasts of a DPD deficient pediatric patient and family members using a polyclonal antibody to human DPD.使用针对人二氢嘧啶脱氢酶（DPD）的多克隆抗体，测定一名DPD缺乏的儿科患者及其家庭成员成纤维细胞中的二氢嘧啶脱氢酶（DPD）。
Adv Exp Med Biol. 1994;370:7-10. doi: 10.1007/978-1-4615-2584-4_2.
7
Clinical and biochemical abnormalities in a patient with dihydropyrimidine dehydrogenase deficiency due to homozygosity for the C29R mutation.
J Inherit Metab Dis. 1999 Apr;22(2):191-2. doi: 10.1023/a:1005470524203.
8
Defects of pyrimidine degradation: clinical, molecular and diagnostic aspects.嘧啶降解缺陷：临床、分子及诊断方面
Adv Exp Med Biol. 2000;486:233-41. doi: 10.1007/0-306-46843-3_46.
9
Combined deficiencies of NADPH- and NADH-dependent dihydropyrimidine dehydrogenases, a new finding in a family with thymine-uraciluria.NADPH和NADH依赖的二氢嘧啶脱氢酶联合缺乏症：一个患有胸腺嘧啶-尿嘧啶尿症的家族中的新发现
J Inherit Metab Dis. 1995;18(2):185-8. doi: 10.1007/BF00711762.
10
Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.
Clin Chim Acta. 1984 Aug 31;141(2-3):227-34. doi: 10.1016/0009-8981(84)90014-7.

引用本文的文献

1
Identification of diagnostic markers and molecular clusters of cuproptosis-related genes in alcohol-related liver disease based on machine learning and experimental validation.基于机器学习和实验验证的酒精性肝病中铜死亡相关基因的诊断标志物和分子簇的鉴定
Heliyon. 2024 Sep 12;10(18):e37612. doi: 10.1016/j.heliyon.2024.e37612. eCollection 2024 Sep 30.
2
Integrated Metabolomics and Proteomics Analysis of Urine in a Mouse Model of Posttraumatic Stress Disorder.创伤后应激障碍小鼠模型尿液的综合代谢组学和蛋白质组学分析
Front Neurosci. 2022 Mar 11;16:828382. doi: 10.3389/fnins.2022.828382. eCollection 2022.
3
Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer.
在 1800 名晚期结直肠癌患者中，进行了全基因组关联研究，以评估奥沙利铂和氟嘧啶化疗联合或不联合西妥昔单抗的毒性。
Int J Cancer. 2021 Nov 1;149(9):1713-1722. doi: 10.1002/ijc.33739. Epub 2021 Jul 31.
4
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants.携带多种二氢嘧啶脱氢酶（DPYD）变体患者的氟嘧啶治疗的诊断和治疗策略
Genes (Basel). 2018 Nov 28;9(12):585. doi: 10.3390/genes9120585.
5
Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.药物代谢酶和转运体的遗传药理学：对抗癌药物药代动力学和药效学的影响。
Anticancer Agents Med Chem. 2010 Oct 1;10(8):583-92. doi: 10.2174/187152010794474019.
6
How may anticancer chemotherapy with fluorouracil be individualised?氟尿嘧啶的抗癌化疗如何实现个体化？
Clin Pharmacokinet. 2006;45(6):567-92. doi: 10.2165/00003088-200645060-00002.
7
Physiologically based pharmacokinetic modelling of the three-step metabolism of pyrimidine using C-uracil as an in vivo probe.以C-尿嘧啶作为体内探针的嘧啶三步代谢的生理药代动力学建模。
Br J Clin Pharmacol. 2005 Dec;60(6):584-93. doi: 10.1111/j.1365-2125.2005.02472.x.
8
Pharmacogenomics: marshalling the human genome to individualise drug therapy.药物基因组学：利用人类基因组实现药物治疗个体化。
Gut. 2003 May;52 Suppl 2(Suppl 2):ii10-8. doi: 10.1136/gut.52.suppl_2.ii10.
9
Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.埃及人群中多态性细胞色素P450（CYP2C9、CYP2C19、CYP2E1）和二氢嘧啶脱氢酶（DPYD）的等位基因及基因型频率
Br J Clin Pharmacol. 2002 Jun;53(6):596-603. doi: 10.1046/j.1365-2125.2002.01604.x.
10
Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations.西南亚、肯尼亚和加纳人群中二氢嘧啶脱氢酶活性的评估。
Br J Clin Pharmacol. 2000 Sep;50(3):269-72. doi: 10.1046/j.1365-2125.2000.00242.x.